Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis
Introduction Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antib...
Saved in:
Published in | Annals of nuclear medicine Vol. 38; no. 4; pp. 247 - 263 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Singapore
Springer Nature Singapore
01.04.2024
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Introduction
Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals.
Methods
According to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including
18
F,
64
Cu,
68
Ga,
89
Zr,
177
Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [
68
Ga]-FAPI-46 and macromolecular drugs such as [
89
Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models.
Results
Functional tests for Mortenon M1 module system were conducted, with [
68
Ga]-FAPI-46 and [
89
Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([
68
Ga]-FAPI-46, 70.63% ± 2.85%,
n
= 10; [
89
Zr]-TROP2, 82.31% ± 3.92%,
n
= 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis.
Conclusion
This study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals. |
---|---|
AbstractList | Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals.INTRODUCTIONFunctions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals.According to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including 18F, 64Cu, 68Ga, 89Zr, 177Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [68Ga]-FAPI-46 and macromolecular drugs such as [89Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models.METHODSAccording to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including 18F, 64Cu, 68Ga, 89Zr, 177Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [68Ga]-FAPI-46 and macromolecular drugs such as [89Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models.Functional tests for Mortenon M1 module system were conducted, with [68Ga]-FAPI-46 and [89Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([68Ga]-FAPI-46, 70.63% ± 2.85%, n = 10; [89Zr]-TROP2, 82.31% ± 3.92%, n = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis.RESULTSFunctional tests for Mortenon M1 module system were conducted, with [68Ga]-FAPI-46 and [89Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([68Ga]-FAPI-46, 70.63% ± 2.85%, n = 10; [89Zr]-TROP2, 82.31% ± 3.92%, n = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis.This study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals.CONCLUSIONThis study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals. IntroductionFunctions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals.MethodsAccording to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including 18F, 64Cu, 68Ga, 89Zr, 177Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [68Ga]-FAPI-46 and macromolecular drugs such as [89Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models.ResultsFunctional tests for Mortenon M1 module system were conducted, with [68Ga]-FAPI-46 and [89Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([68Ga]-FAPI-46, 70.63% ± 2.85%, n = 10; [89Zr]-TROP2, 82.31% ± 3.92%, n = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis.ConclusionThis study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals. Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals. According to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including F, Cu, Ga, Zr, Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [ Ga]-FAPI-46 and macromolecular drugs such as [ Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models. Functional tests for Mortenon M1 module system were conducted, with [ Ga]-FAPI-46 and [ Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([ Ga]-FAPI-46, 70.63% ± 2.85%, n = 10; [ Zr]-TROP2, 82.31% ± 3.92%, n = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis. This study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals. Introduction Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few modules which have achieved full-automatic radiolabeling of non-metallic and metallic nuclides on small molecules, peptides, and antibody drugs. This study aimed to develop and test a full-automatic multifunctional module system for the safe, stable, and efficient production of radiopharmaceuticals. Methods According to characteristics of labeling process of radioactive drugs, using UG and Solidworks softwares, full-automatic cassette-based synthesis module system Mortenon M1 for synthesis of radiopharmaceuticals with various radionuclides, was designed and tested. Mortenon M1 has at least three significant highlights: the cassettes are disposable, and there is no need of manual cleaning; the synthesis method program is flexible and can be edited freely by users according to special needs; this module system is suitable for radiolabeling of both small-molecule and macromolecular drugs, with potentially various radionuclides including 18 F, 64 Cu, 68 Ga, 89 Zr, 177 Lu, etc. By program control methods for certain drugs, Mortenon M1 was used for radiolabeling of both small-molecule drugs such as [ 68 Ga]-FAPI-46 and macromolecular drugs such as [ 89 Zr]-TROP2 antibody. Quality control assays for product purity were performed with radio-iTLC and radio-HPLC, and the radiotracers were confirmed for application in microPET imaging in xenograft tumor-bearing mouse models. Results Functional tests for Mortenon M1 module system were conducted, with [ 68 Ga]-FAPI-46 and [ 89 Zr]-TROP2 antibody as goal synthetic products, and it displayed that with the cassette modules, the preset goals could be achieved successfully. The radiolabeling synthesis yield was good ([ 68 Ga]-FAPI-46, 70.63% ± 2.85%, n = 10; [ 89 Zr]-TROP2, 82.31% ± 3.92%, n = 10), and the radiochemical purity via radio-iTLC assay of the radiolabeled products was above 99% after purification. MicroPET imaging results showed that the radiolabeled tracers had reasonable radioactive distribution in MDA-MB-231 and SNU-620 xenograft tumor-bearing mice, and the tumor targeted radiouptake was satisfactory for diagnosis. Conclusion This study demonstrated that the full-automatic module system Mortenon M1 is efficient for radiolabeling synthesis of both small-molecule and macromolecular substrates. It may be helpful to reduce radiation exposure for safety, provide qualified radiolabeled products and reliable PET diagnosis, and ensure stable production and supply of radiopharmaceuticals. |
Author | Cui, Fang-Bo Lv, Xuan Yan, Cheng-Long Eng, Wai-Si Zheng, Qi-Huang Yu, Shan-You |
Author_xml | – sequence: 1 givenname: Fang-Bo surname: Cui fullname: Cui, Fang-Bo organization: Department of Oncology, The People’s Hospital of Ma Anshan – sequence: 2 givenname: Xuan surname: Lv fullname: Lv, Xuan organization: Norroy Bioscience Co., Ltd – sequence: 3 givenname: Cheng-Long surname: Yan fullname: Yan, Cheng-Long organization: Norroy Bioscience Co., Ltd – sequence: 4 givenname: Wai-Si surname: Eng fullname: Eng, Wai-Si organization: Norroy Bioscience Co., Ltd – sequence: 5 givenname: Shan-You surname: Yu fullname: Yu, Shan-You email: yushanyou@norroybioscience.com organization: Norroy Bioscience Co., Ltd – sequence: 6 givenname: Qi-Huang surname: Zheng fullname: Zheng, Qi-Huang email: qzheng@iupui.edu organization: Department of Radiology and Imaging Sciences, Indiana University School of Medicine |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38145430$$D View this record in MEDLINE/PubMed |
BookMark | eNp90U1rFTEUBuAgFXtb_QMuJOCmm9F8TSZZSq2t0NJNXQ-ZzImdkknGfAh34X839lYFF64C4XlPDnlP0FGIARB6Tck7SsjwPlNGhe4I4x2hSvOOPUM7qqTopOD8CO2IpqIbqBqO0UnOD4Qw1Sv2Ah1zRUUvONmhHx_hO_i4rRAKNmHGZtv8Yk1ZYsDRYYNd9X6PTS1xbbcWr9WXpXM12EdjTc5QCuA1ztUDvompQFsU31DsYsLJzEvc7k1ajYXaBhiP8z6Ue8hLfomeO-MzvHo6T9GXTxd351fd9e3l5_MP153lPSmdnIDSQTsyTJNg1BIpiGZiBpDUcuIc0bMUDiyd1GSN7jntZwW9U1Jr3Vt-is4Oc7cUv1XIZVyXbMF7EyDWPDJN-kFRqVWjb_-hD7Gm0LZramADk0zSpt48qTqtMI9bWlaT9uPvj22AHYBNMecE7g-hZPzV3nhob2ztjY_tjayF-CGUGw5fIf19-z-pn-Jznd0 |
Cites_doi | 10.1016/j.apradiso.2020.109468 10.1002/jlcr.3706 10.1007/s00259-021-05563-1 10.18893/kakuigaku.oa.1802 10.1016/j.apradiso.2012.03.006 10.1186/s41181-019-0077-0 10.1039/d2re00219arsc.li/reaction-engineering 10.1039/d1lc00148e 10.1016/j.apradiso.2012.09.010 10.3390/ijms20225579 10.3390/ph10040077 10.1186/2191-219X-3-52 10.1620/tjem.211.379 10.2967/jnumed.113.132472 10.1002/jlcr.1865 10.1186/s41181-022-00172-1 10.1186/s41181-020-00095-9 10.1002/jlcr.1937 10.1038/nprot.2016.060 10.2174/1389450117666160720091233 10.1007/s00259-021-05266-7 10.1016/j.ijpharm.2014.01.034 10.1016/j.apradiso.2017.02.030 10.1016/j.apradiso.2006.06.016 10.3791/63025 10.1007/978-3-540-49527-7_11 10.1016/j.nucmedbio.2014.12.010 10.1016/j.apradiso.2010.06.023 10.1016/j.apradiso.2016.02.016 10.1136/jitc-2022-004848 10.1016/j.apradiso.2013.05.009 10.1186/s41181-016-0018-0 10.3390/molecules27030675 |
ContentType | Journal Article |
Copyright | The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine. |
Copyright_xml | – notice: The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7TK K9. NAPCQ 7X8 |
DOI | 10.1007/s12149-023-01893-2 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium Calcium & Calcified Tissue Abstracts Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1864-6433 |
EndPage | 263 |
ExternalDocumentID | 38145430 10_1007_s12149_023_01893_2 |
Genre | Journal Article |
GroupedDBID | --- -53 -5E -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 1N0 2.D 203 23M 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2WC 2~H 30V 3V. 4.4 406 408 40D 40E 53G 5GY 5VS 67Z 6J9 6NX 7RV 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ 8G5 8TC 8UJ 8WZ 95- 95. 95~ 96X A6W AAAVM AABHQ AACDK AAEWM AAHNG AAIAL AAJBT AAJKR AANXM AANZL AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAWTL AAYIU AAYQN AAYTO AAYZH ABAKF ABDZT ABECU ABFTV ABHLI ABHQN ABIPD ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABPLI ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABWNU ABXPI ACAOD ACDTI ACGFO ACGFS ACHSB ACHXU ACIHN ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACREN ACSNA ACUDM ACZOJ ADBBV ADHHG ADHIR ADINQ ADJJI ADKNI ADKPE ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEVLU AEXYK AFBBN AFKRA AFLOW AFQWF AFRAH AFWTZ AFYQB AFZKB AGAYW AGDGC AGJBK AGMZJ AGQEE AGQMX AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIGIU AIIXL AILAN AITGF AJBLW AJRNO AJZVZ AKMHD ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARAPS ARMRJ ASPBG AVWKF AXYYD AZFZN AZQEC B-. BA0 BAWUL BBNVY BBWZM BDATZ BENPR BGLVJ BGNMA BHPHI BKEYQ BPHCQ BVXVI C1A CAG CCPQU COF CS3 CSCUP DDRTE DIK DNIVK DPUIP DWQXO EBD EBLON EBS EIOEI EJD EMOBN EN4 ESBYG EX3 F5P FERAY FFXSO FIGPU FINBP FNLPD FRP FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ6 GQ7 GRRUI GUQSH GX1 H13 HCIFZ HF~ HG5 HG6 HMCUK HMJXF HRMNR HZ~ IJ- IKXTQ IMOTQ IWAJR IXD IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KOV KPH LK8 LLZTM M1P M2O M4Y M7P MA- N9A NAPCQ NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM OVD P2P P62 P6G P9S PF0 PQQKQ PROAC PSQYO PT4 Q2X QOK QOR QOS R89 R9I RHV RNS ROL RPX RSV S16 S1Z S27 S37 S3B SAP SCLPG SDE SDH SHX SISQX SJN SJYHP SMD SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 TEORI TKC TR2 TSG TSK TSV TT1 TUC U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W2D W48 WJK WK8 WOW X7M XSB YLTOR Z45 Z7U Z7X Z82 Z83 Z87 Z8O Z8V Z91 ZMTXR ZOVNA ~A9 AAPKM AAYXX ABBRH ABDBE ABFSG ACMFV ACSTC AEZWR AFDZB AFHIU AFOHR AHPBZ AHWEU AIXLP ATHPR AYFIA CITATION OVT PHGZM PHGZT ABRTQ CGR CUY CVF ECM EIF NPM PJZUB PPXIY PQGLB 7QP 7TK K9. 7X8 |
ID | FETCH-LOGICAL-c350t-6be1179f07bb421c0640924dee61c30ff09d64fec1b8bca95315d8e5f869995c3 |
IEDL.DBID | U2A |
ISSN | 0914-7187 1864-6433 |
IngestDate | Thu Jul 10 23:38:13 EDT 2025 Fri Jul 25 19:14:54 EDT 2025 Mon Jul 21 05:57:11 EDT 2025 Tue Jul 01 02:35:02 EDT 2025 Fri Feb 21 02:39:33 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Automatic module Ga]-FAPI-46 Zr]-TROP2 antibody [ Radiopharmaceuticals Labeling synthesis [89Zr]-TROP2 antibody [68Ga]-FAPI-46 |
Language | English |
License | 2023. The Author(s) under exclusive licence to The Japanese Society of Nuclear Medicine. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c350t-6be1179f07bb421c0640924dee61c30ff09d64fec1b8bca95315d8e5f869995c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 38145430 |
PQID | 2972726261 |
PQPubID | 54108 |
PageCount | 17 |
ParticipantIDs | proquest_miscellaneous_2905781698 proquest_journals_2972726261 pubmed_primary_38145430 crossref_primary_10_1007_s12149_023_01893_2 springer_journals_10_1007_s12149_023_01893_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2024-04-01 |
PublicationDateYYYYMMDD | 2024-04-01 |
PublicationDate_xml | – month: 04 year: 2024 text: 2024-04-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Singapore |
PublicationPlace_xml | – name: Singapore – name: Japan – name: Tokyo |
PublicationTitle | Annals of nuclear medicine |
PublicationTitleAbbrev | Ann Nucl Med |
PublicationTitleAlternate | Ann Nucl Med |
PublicationYear | 2024 |
Publisher | Springer Nature Singapore Springer Nature B.V |
Publisher_xml | – name: Springer Nature Singapore – name: Springer Nature B.V |
References | Da Pieve, Costa Braga, Turton, Valla, Cakmak, Plate (CR9) 2022; 27 Cardinale, Martin, Remde, Schäfer, Hienzsch, Hübner (CR11) 2017; 10 Hoareau, Shao, Henderson, Scott (CR25) 2012; 70 Garcia-Arguello, Lopez-Lorenzo, Ruiz-Cruces (CR35) 2019; 62 CR16 Boschi, Lodi, Malizia, Cicoria, Marengo (CR34) 2013; 76 Zaheer, Kim, Lee, Kim, Lim (CR2) 2019; 20 Nakamura, Matsumura, Yamamoto, Senda (CR12) 2019; 56 Oh, Chi, Mosdzianowski, Kil, Ryu, Moon (CR23) 2007; 65 Yue, Nikam, Kecskemethy, Kandula, Falchek, Averill (CR8) 2021 Ovdiichuk, Mallapura, Pineda, Hourtané, Långström, Halldin (CR24) 2021; 21 Wang, Chuang, Chiu, Cham, Chung (CR4) 2007; 211 Shao, Hoareau, Runkle, Tluczek, Hockley, Henderson, Scott (CR30) 2011; 54 Cagnolini, Chen, Ramos, Skedzielewski, Lantry, Nunn (CR17) 2010; 68 Krasikova (CR31) 2007; 62 Li, Schmitz, Lee, Mach (CR28) 2017; 1 Ferdinandus, Kessler, Hirmas, Trajkovic-Arsic, Hamacher, Umutlu (CR14) 2021; 48 Shao, Hoareau, Hockley, Tluczek, Henderson, Padgett, Scott (CR29) 2011; 54 Aalbersberg, van Andel, Geluk-Jonker, Beijnen, Stokkel, Hendrikx (CR21) 2020; 5 Toyohara, Nishino, Sakai, Tago, Oda (CR7) 2021; 168 Frank, Winter, Rensei, Samper, Brooks, Hockley, Henderson, Rensch, Scott (CR32) 2019; 4 Sun, Henry, Laville, Carré, Hamaoui, Bockel (CR1) 2022; 10 Schwarz, Dick, VanBrocklin, Hoffman (CR22) 2014; 55 Mueller, Breeman, Klette, Gottschaldt, Odparlik, Baehre (CR13) 2016; 11 Lazari, Quinn, Claggett, Collins, Shah, Herman (CR18) 2013; 3 Patt, Schildan, Habermann, Fischer, Hiller, Deuther-Conrad (CR10) 2013; 80 Sharma (CR6) 2016; 17 Zhang, Basuli, Shi, Xu, Blackman, Choyke (CR26) 2016; 112 Bruton, Scott (CR27) 2020 ter Heine, Lange, Breukels, Bloemendal, Rummenie, Wakker (CR3) 2014; 465 Chen, Li, Younis, Barnhart, Jiang, Sun (CR15) 2022; 49 Alfteimi, Lützen, Helm, Jüptner, Marx, Zhao (CR20) 2022; 7 Revunov, Jørgensen, Jensen, Hansen, Severin, Kjær (CR5) 2015; 42 Barnes, Nair, Aboagye, Archibald, Allott (CR33) 2022; 7 Liu, Nie, Jiang, Tang (CR19) 2017; 123 R ter Heine (1893_CR3) 2014; 465 YF Wang (1893_CR4) 2007; 211 C Frank (1893_CR32) 2019; 4 J Ferdinandus (1893_CR14) 2021; 48 J Zaheer (1893_CR2) 2019; 20 J Toyohara (1893_CR7) 2021; 168 S Liu (1893_CR19) 2017; 123 X Shao (1893_CR30) 2011; 54 O Ovdiichuk (1893_CR24) 2021; 21 T Nakamura (1893_CR12) 2019; 56 M Patt (1893_CR10) 2013; 80 S Boschi (1893_CR34) 2013; 76 X Yue (1893_CR8) 2021 D Mueller (1893_CR13) 2016; 11 J Cardinale (1893_CR11) 2017; 10 EA Aalbersberg (1893_CR21) 2020; 5 SJ Oh (1893_CR23) 2007; 65 X Shao (1893_CR29) 2011; 54 R Sun (1893_CR1) 2022; 10 E Revunov (1893_CR5) 2015; 42 R Krasikova (1893_CR31) 2007; 62 SW Schwarz (1893_CR22) 2014; 55 C Da Pieve (1893_CR9) 2022; 27 S Sharma (1893_CR6) 2016; 17 A Alfteimi (1893_CR20) 2022; 7 SF Garcia-Arguello (1893_CR35) 2019; 62 1893_CR16 R Hoareau (1893_CR25) 2012; 70 L Bruton (1893_CR27) 2020 W Chen (1893_CR15) 2022; 49 M Lazari (1893_CR18) 2013; 3 S Li (1893_CR28) 2017; 1 C Barnes (1893_CR33) 2022; 7 A Cagnolini (1893_CR17) 2010; 68 X Zhang (1893_CR26) 2016; 112 |
References_xml | – volume: 168 year: 2021 ident: CR7 article-title: Automated production of [18F]MK-6240 on CFN-MPS200 publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2020.109468 – volume: 62 start-page: 146 issue: 3 year: 2019 end-page: 153 ident: CR35 article-title: Automated production of [ Ga]Ga-DOTANOC and [ Ga]Ga-PSMA-11 using a TRACERlab FXFN synthesis module publication-title: J Labelled Comp Radiopharm doi: 10.1002/jlcr.3706 – volume: 49 start-page: 861 issue: 3 year: 2022 end-page: 870 ident: CR15 article-title: ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-021-05563-1 – volume: 56 start-page: 127 issue: 1 year: 2019 end-page: 134 ident: CR12 article-title: Safety and effectiveness of NEPTIS Plug-01 and Florbetapir ( F) in daily clinical setting: based on the post-marketing surveillance study publication-title: Kaku Igaku doi: 10.18893/kakuigaku.oa.1802 – volume: 70 start-page: 1779 issue: 8 year: 2012 end-page: 1783 ident: CR25 article-title: Fully automated radiosynthesis of [ C]PBR28, a radiopharmaceutical for the translocator protein (TSPO) 18 kDa, using a GE TRACERlab FXC-Pro publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2012.03.006 – volume: 4 start-page: 24 issue: 1 year: 2019 ident: CR32 article-title: Development and implementation of ISAR, a new synthesis platform for radiopharmaceutical production publication-title: EJNMMI Radiopharm Chem doi: 10.1186/s41181-019-0077-0 – volume: 7 start-page: 2265 year: 2022 end-page: 2279 ident: CR33 article-title: A practical guide to automating fluorine-18 PET radiochemistry using commercially available cassette-based platforms publication-title: React Chem Eng doi: 10.1039/d2re00219arsc.li/reaction-engineering – volume: 21 start-page: 2272 issue: 11 year: 2021 end-page: 2282 ident: CR24 article-title: Implementation of iMiDEV™, a new fully automated microfluidic platform for radiopharmaceutical production publication-title: Lab Chip doi: 10.1039/d1lc00148e – ident: CR16 – year: 2020 ident: CR27 article-title: Automated synthesis modules for PET radiochemistry publication-title: Handbook of radiopharmaceuticals – volume: 76 start-page: 38 year: 2013 end-page: 45 ident: CR34 article-title: Automation synthesis modules review publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2012.09.010 – volume: 20 start-page: 5579 issue: 22 year: 2019 ident: CR2 article-title: Combination radioimmunotherapy strategies for solid tumors publication-title: Int J Mol Sci doi: 10.3390/ijms20225579 – volume: 10 start-page: 77 issue: 4 year: 2017 ident: CR11 article-title: Procedures for the GMP-compliant production and quality control of [ F]PSMA-1007: a next generation radiofluorinated tracer for the detection of prostate cancer publication-title: Pharmaceuticals (Basel) doi: 10.3390/ph10040077 – volume: 3 start-page: 52 issue: 1 year: 2013 ident: CR18 article-title: ELIXYS - a fully automated, three-reactor high-pressure radiosynthesizer for development and routine production of diverse PET tracers publication-title: EJNMMI Res doi: 10.1186/2191-219X-3-52 – volume: 211 start-page: 379 issue: 4 year: 2007 end-page: 385 ident: CR4 article-title: On-site preparation of technetium-99m labeled human serum albumin for clinical application publication-title: Tohoku J Exp Med doi: 10.1620/tjem.211.379 – volume: 55 start-page: 1132 issue: 7 year: 2014 end-page: 1137 ident: CR22 article-title: Regulatory requirements for PET drug production publication-title: J Nucl Med doi: 10.2967/jnumed.113.132472 – volume: 54 start-page: 292 issue: 6 year: 2011 end-page: 307 ident: CR29 article-title: Highlighting the versatility of the tracerlab synthesis modules. Part 1: fully automated production of [F]labelled radiopharmaceuticals using a Tracerlab FX(FN) publication-title: J Labelled Comp Radiopharm. doi: 10.1002/jlcr.1865 – volume: 7 start-page: 20 issue: 1 year: 2022 ident: CR20 article-title: Automated synthesis of [ Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types publication-title: EJNMMI Radiopharm Chem doi: 10.1186/s41181-022-00172-1 – volume: 5 start-page: 10 issue: 1 year: 2020 ident: CR21 article-title: Automated synthesis and quality control of [ Tc]Tc-PSMA for radioguided surgery (in a [ Ga]Ga-PSMA workflow) publication-title: EJNMMI Radiopharm Chem doi: 10.1186/s41181-020-00095-9 – volume: 54 start-page: 819 year: 2011 end-page: 838 ident: CR30 article-title: Highlighting the versatility of the Tracerlab synthesis modules. Part 2: fully automated production of [11C]-labeled radiopharmaceuticals using a Tracerlab FXC-Pro publication-title: J Label Compd Radiopharm doi: 10.1002/jlcr.1937 – volume: 11 start-page: 1057 issue: 6 year: 2016 end-page: 1066 ident: CR13 article-title: Radiolabeling of DOTA-like conjugated peptides with generator-produced Ga and using NaCl-based cationic elution method publication-title: Nat Protoc doi: 10.1038/nprot.2016.060 – volume: 17 start-page: 1894 issue: 16 year: 2016 end-page: 1907 ident: CR6 article-title: PET radiopharmaceuticals for personalized medicine publication-title: Curr Drug Targets doi: 10.2174/1389450117666160720091233 – volume: 48 start-page: 3221 issue: 10 year: 2021 end-page: 3227 ident: CR14 article-title: Equivalent tumor detection for early and late FAPI-46 PET acquisition publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-021-05266-7 – volume: 465 start-page: 317 issue: 1–2 year: 2014 end-page: 324 ident: CR3 article-title: Bench to bedside development of GMP grade Rhenium-188-HEDP, a radiopharmaceutical for targeted treatment of painful bone metastases publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2014.01.034 – volume: 123 start-page: 49 year: 2017 end-page: 53 ident: CR19 article-title: Efficient automated synthesis of 2-(5-[ F]fluoropentyl)-2-methylmalonic acid ([ F]ML-10) on a commercial available [ F]FDG synthesis module publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2017.02.030 – volume: 65 start-page: 676 issue: 6 year: 2007 end-page: 681 ident: CR23 article-title: The automatic production of 16alpha-[ F]fluoroestradiol using a conventional [ F]FDG module with a disposable cassette system publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2006.06.016 – year: 2021 ident: CR8 article-title: Radiosynthesis of 1-(2-[ F]Fluoroethyl)-L-Tryptophan using a one-pot, two-step protocol publication-title: J Vis Exp doi: 10.3791/63025 – volume: 62 start-page: 289 year: 2007 end-page: 316 ident: CR31 article-title: Synthesis modules and automation in F-18 labeling publication-title: Ernst Scher Res Found Workshop doi: 10.1007/978-3-540-49527-7_11 – volume: 42 start-page: 413 issue: 4 year: 2015 end-page: 419 ident: CR5 article-title: Automated synthesis and PET evaluation of both enantiomers of [ F]FMISO publication-title: Nucl Med Biol doi: 10.1016/j.nucmedbio.2014.12.010 – volume: 68 start-page: 2285 issue: 12 year: 2010 end-page: 2292 ident: CR17 article-title: Automated synthesis, characterization and biological evaluation of [(68)Ga]Ga-AMBA, and the synthesis and characterization of (nat)Ga-AMBA and [(67)Ga]Ga-AMBA publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2010.06.023 – volume: 112 start-page: 110 year: 2016 end-page: 114 ident: CR26 article-title: Automated synthesis of [(18)F](2S,4R)-4-fluoroglutamine on a GE TRACERlab™ FX-N Pro module publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2016.02.016 – volume: 10 issue: 7 year: 2022 ident: CR1 article-title: Imaging approaches and radiomics: toward a new era of ultraprecision radioimmunotherapy? publication-title: J Immunother Cancer doi: 10.1136/jitc-2022-004848 – volume: 80 start-page: 7 year: 2013 end-page: 11 ident: CR10 article-title: Fully automated radiosynthesis of both enantiomers of [ F]Flubatine under GMP conditions for human application publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2013.05.009 – volume: 1 start-page: 15 issue: 1 year: 2017 ident: CR28 article-title: Automation of the radiosynthesis of six different F-labeled radiotracers on the AllinOne publication-title: EJNMMI Radiopharm Chem doi: 10.1186/s41181-016-0018-0 – volume: 27 start-page: 675 issue: 3 year: 2022 ident: CR9 article-title: New fully automated preparation of high apparent molar activity Ga-FAPI-46 on a Trasis AiO platform publication-title: Molecules doi: 10.3390/molecules27030675 – volume: 465 start-page: 317 issue: 1–2 year: 2014 ident: 1893_CR3 publication-title: Int J Pharm doi: 10.1016/j.ijpharm.2014.01.034 – volume: 3 start-page: 52 issue: 1 year: 2013 ident: 1893_CR18 publication-title: EJNMMI Res doi: 10.1186/2191-219X-3-52 – volume: 10 start-page: 77 issue: 4 year: 2017 ident: 1893_CR11 publication-title: Pharmaceuticals (Basel) doi: 10.3390/ph10040077 – volume: 62 start-page: 146 issue: 3 year: 2019 ident: 1893_CR35 publication-title: J Labelled Comp Radiopharm doi: 10.1002/jlcr.3706 – volume: 10 issue: 7 year: 2022 ident: 1893_CR1 publication-title: J Immunother Cancer doi: 10.1136/jitc-2022-004848 – volume: 1 start-page: 15 issue: 1 year: 2017 ident: 1893_CR28 publication-title: EJNMMI Radiopharm Chem doi: 10.1186/s41181-016-0018-0 – volume: 54 start-page: 292 issue: 6 year: 2011 ident: 1893_CR29 publication-title: J Labelled Comp Radiopharm. doi: 10.1002/jlcr.1865 – volume: 68 start-page: 2285 issue: 12 year: 2010 ident: 1893_CR17 publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2010.06.023 – volume: 112 start-page: 110 year: 2016 ident: 1893_CR26 publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2016.02.016 – volume: 76 start-page: 38 year: 2013 ident: 1893_CR34 publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2012.09.010 – volume: 48 start-page: 3221 issue: 10 year: 2021 ident: 1893_CR14 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-021-05266-7 – volume: 21 start-page: 2272 issue: 11 year: 2021 ident: 1893_CR24 publication-title: Lab Chip doi: 10.1039/d1lc00148e – volume: 168 year: 2021 ident: 1893_CR7 publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2020.109468 – year: 2021 ident: 1893_CR8 publication-title: J Vis Exp doi: 10.3791/63025 – volume: 55 start-page: 1132 issue: 7 year: 2014 ident: 1893_CR22 publication-title: J Nucl Med doi: 10.2967/jnumed.113.132472 – volume: 62 start-page: 289 year: 2007 ident: 1893_CR31 publication-title: Ernst Scher Res Found Workshop doi: 10.1007/978-3-540-49527-7_11 – volume-title: Handbook of radiopharmaceuticals year: 2020 ident: 1893_CR27 – volume: 49 start-page: 861 issue: 3 year: 2022 ident: 1893_CR15 publication-title: Eur J Nucl Med Mol Imaging doi: 10.1007/s00259-021-05563-1 – volume: 70 start-page: 1779 issue: 8 year: 2012 ident: 1893_CR25 publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2012.03.006 – volume: 80 start-page: 7 year: 2013 ident: 1893_CR10 publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2013.05.009 – volume: 5 start-page: 10 issue: 1 year: 2020 ident: 1893_CR21 publication-title: EJNMMI Radiopharm Chem doi: 10.1186/s41181-020-00095-9 – volume: 211 start-page: 379 issue: 4 year: 2007 ident: 1893_CR4 publication-title: Tohoku J Exp Med doi: 10.1620/tjem.211.379 – volume: 20 start-page: 5579 issue: 22 year: 2019 ident: 1893_CR2 publication-title: Int J Mol Sci doi: 10.3390/ijms20225579 – volume: 27 start-page: 675 issue: 3 year: 2022 ident: 1893_CR9 publication-title: Molecules doi: 10.3390/molecules27030675 – volume: 42 start-page: 413 issue: 4 year: 2015 ident: 1893_CR5 publication-title: Nucl Med Biol doi: 10.1016/j.nucmedbio.2014.12.010 – volume: 7 start-page: 2265 year: 2022 ident: 1893_CR33 publication-title: React Chem Eng doi: 10.1039/d2re00219arsc.li/reaction-engineering – volume: 56 start-page: 127 issue: 1 year: 2019 ident: 1893_CR12 publication-title: Kaku Igaku doi: 10.18893/kakuigaku.oa.1802 – ident: 1893_CR16 – volume: 54 start-page: 819 year: 2011 ident: 1893_CR30 publication-title: J Label Compd Radiopharm doi: 10.1002/jlcr.1937 – volume: 11 start-page: 1057 issue: 6 year: 2016 ident: 1893_CR13 publication-title: Nat Protoc doi: 10.1038/nprot.2016.060 – volume: 123 start-page: 49 year: 2017 ident: 1893_CR19 publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2017.02.030 – volume: 7 start-page: 20 issue: 1 year: 2022 ident: 1893_CR20 publication-title: EJNMMI Radiopharm Chem doi: 10.1186/s41181-022-00172-1 – volume: 4 start-page: 24 issue: 1 year: 2019 ident: 1893_CR32 publication-title: EJNMMI Radiopharm Chem doi: 10.1186/s41181-019-0077-0 – volume: 17 start-page: 1894 issue: 16 year: 2016 ident: 1893_CR6 publication-title: Curr Drug Targets doi: 10.2174/1389450117666160720091233 – volume: 65 start-page: 676 issue: 6 year: 2007 ident: 1893_CR23 publication-title: Appl Radiat Isot doi: 10.1016/j.apradiso.2006.06.016 |
SSID | ssj0028582 |
Score | 2.3600981 |
Snippet | Introduction
Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There... Functions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There are few... IntroductionFunctions of existing automatic module systems for synthesis of radiopharmaceuticals mainly focus on the radiolabeling of small molecules. There... |
SourceID | proquest pubmed crossref springer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 247 |
SubjectTerms | Animal models Animals Antibodies Cassettes Chemical synthesis Control methods Diagnosis Drugs Functional testing Gallium isotopes Gallium Radioisotopes - chemistry Humans Imaging Macromolecules Medicine Medicine & Public Health Mice Modules Neoplasms Nuclear Medicine Nuclides Original Article Peptides Pharmaceuticals Production methods Purity Quality control Radiation effects Radioactive tracers Radiochemistry Radioisotopes Radioisotopes - chemistry Radiolabelling Radiology Radiopharmaceuticals - chemistry Substrates Tumors Xenografts Xenotransplantation Zirconium isotopes |
Title | Development and application of a fully automatic multi-function cassette module Mortenon M1 for radiopharmaceutical synthesis |
URI | https://link.springer.com/article/10.1007/s12149-023-01893-2 https://www.ncbi.nlm.nih.gov/pubmed/38145430 https://www.proquest.com/docview/2972726261 https://www.proquest.com/docview/2905781698 |
Volume | 38 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxshEB7lIUW5VG2e26YWkXJrkRYW1uzRqvJQIvdUS85pBSwokZJdK2sfcuh_74B3bVdpDj2DADHAfMP3MQBceKNSz4eOVujcqNCZoNoOJdVecWZ4aoQP9x3jn_nNRNxO5bR7FNb2aveekown9fqxG0c0T9HHYPiLXpbiwbsrMXYPQq4JH63CLCXjF1HoCIPSUA27pzL_buNvd_QGY77hR6PbufoIHzq8SEZLA3-CLVcfwN64Y8QP4feG6ofouiIbjDRpPNEkXLC_Er2YNzE7K4kSQhr8WaxjET0HuQ95bqrFkyNRfVtjwZgRBLTkRVePzexh8-abtK814sb2sT2CydXlrx83tPtSgdpMpnOaGxdywPl0aIzgzAYeDyOwyrmc2Sz1Pi2qXHhnmVHG6gJ3qKyUk17liCSlzY5hB4fgToEwZ4zXnGO8JERhtELgkPOiwkaUskwm8K2f2XK2zJxRrnMkBzuUaIcy2qHkCZz1k192u6gteRFoYgy5WALnq2Jc_4HU0LVrFqEOIk7F8kIlcLI02qo7RCNCiixN4HtvxXXj74_l8_9V_wL7uAo7Oc8Z7MxfFu4rIpW5GcDu6Pr-7nIA29dTNojL9A9XTeLK |
linkProvider | Springer Nature |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1BTxQxFH5BSJSLUVEZRKmJnrTJtNPOdg4eiEoWYTmxCbex7bSBRGYIsxuyB_6NP9TX7szuEvTggXObTtPXN-97_b6-AnzwRqWeDxytMLhRoTNBtR1Iqr3izPDUCB_OO0Yn-XAsfpzJszX43d-FiWr3npKMf-rlZTeOaJ5ijMH0F6Ms5Z2U8sjNbjBRa78cfkOrfuT84Pvp1yHt3hKgNpPphObGheJnPh0YIzizgcDC1KNyLmc2S71PiyoX3llmlLG6wK0pK-WkVzlCKGkzHPcRbCD4UMF3xnx_kdYpGZ-kwsAblI1q0F3N-fuc74a_e5j2Hh8bw9zBM3ja4VOyP99Qz2HN1S_g8ahj4LfgdkVlRHRdkRUGnDSeaBIO9GdETydNrAZLomSRhvgZ-1hE60FeRC6bavrLkaj2rbFhxAgCaHKtq4vm6nz1pJ20sxpxanvRvoTxgyz7K1jHKbhtIMwZ4zXnmJ8JURitEKjkvKhwEKUskwl86le2vJpX6iiXNZmDHUq0QxntUPIEdvvFLzuvbUteBFoaUzyWwPtFM_pbIFF07Zpp6IMIV7G8UAm8nhtt8TlEP0KKLE3gc2_F5eD_nsvO_3XfgyfD09FxeXx4cvQGNjmirLmUaBfWJ9dT9xZR0sS8i5uUwM-H9oo_XC0dNQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Nb9QwEB2VIlVcEOWrKS0YCU5gNXacrHPgUFFWLWUrDqzUW7BjW61UklWTVbUH_hM_kbGT7C4qHDj0HMuxPB7NG783Y4A3TsvY8ZGlBoMbFSoRVJWjlConOdM81sL5-47JWXY8FZ_P0_MN-DXUwgS1-0BJdjUNvktT1R7MjDtYFb5xRPYU4w2mwhhxKe9llad2cYNJW_Ph5Agt_Jbz8advH49p_64ALZM0bmmmrW-E5uKR1oKz0pNZmIYYazNWJrFzcW4y4WzJtNSlyvGYpkba1MkM4VRaJjjvPbgvfPUxetCUHy5TPJmG56kwCHuVoxz1ZTp_X_OfofAWvr3FzYaQN34ED3usSg67w7UNG7Z6DFuTno1_Aj_XFEdEVYasseGkdkQRf7m_IGre1qEzLAnyRepjaRhTInL3UiPyozbzK0uC8rfCDxNGEEyTa2Uu69nF-q07aRYVYtbmsnkK0zvZ9mewiUuwO0CY1dopzjFXEyLXSiJoyXhucBIpS5ZG8G7Y2WLWde0oVv2ZvR0KtEMR7FDwCPaGzS96D24KnnuKGtM9FsHr5Wf0PU-oqMrWcz8G0a5kWS4jeN4Zbfk7REIiFUkcwfvBiqvJ_72W3f8b_gq2vh6Niy8nZ6cv4AFHwNWpivZgs72e230ETK1-Gc4oge937RS_AfBoIWg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+and+application+of+a+fully+automatic+multi-function+cassette+module+Mortenon+M1+for+radiopharmaceutical+synthesis&rft.jtitle=Annals+of+nuclear+medicine&rft.au=Cui%2C+Fang-Bo&rft.au=Lv%2C+Xuan&rft.au=Yan%2C+Cheng-Long&rft.au=Eng%2C+Wai-Si&rft.date=2024-04-01&rft.eissn=1864-6433&rft.volume=38&rft.issue=4&rft.spage=247&rft_id=info:doi/10.1007%2Fs12149-023-01893-2&rft_id=info%3Apmid%2F38145430&rft.externalDocID=38145430 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0914-7187&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0914-7187&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0914-7187&client=summon |